Related Experiment Video
Updated: Feb 4, 2026

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
864
Preoperative Embolization for Tentorial and Subtentorial Tumors
Satoshi Koizumi1, Shigeta Fujitani1, Takeru Hirata1
1Department of Neurosurgery, The University of Tokyo, Tokyo, Japan.
Journal of Neuroendovascular Therapy
|February 3, 2026
Summary
Preoperative embolization of tentorial tumors is a safe and effective adjunct to skull base surgery. This technique reduces tumor vascularity and necrosis, aiding complex resections with minimal complications.
Area of Science:
- Neurosurgery
- Interventional Radiology
- Vascular Neurology
Background:
- Tentorial and subtentorial tumors pose surgical challenges due to deep location and complex vascularity.
- Preoperative embolization is a potential adjunct to improve surgical outcomes for these tumors.
- Limited data exists on the safety and efficacy of preoperative embolization for tentorial tumors.
Purpose of the Study:
- To review the technical considerations and outcomes of preoperative embolization for tentorial tumors.
- To evaluate the safety and effectiveness of this procedure in a series of patients.
- To detail the embolization techniques and feeder vessel categories.
Main Methods:
- Retrospective review of 29 consecutive preoperative embolization procedures for tentorial tumors.
- Analysis of technical approaches targeting medial (MHT, ILT), lateral (middle meningeal, occipital arteries), and inferior (APA) feeders.
- Assessment of technical success, embolic agents used, and post-embolization complications.
Main Results:
- Technical success rate of 96.6% (28/29 procedures).
- Embolization primarily from MHT/ILT (53.6%) and APA (21.4%); multiple feeders targeted in 46.6%.
- Predominant embolic agents: N-butyl cyanoacrylate (85.7%), coils (39.3%), particles (35.7%).
- Neurological complications in 7.1% (2/29 cases), primarily cranial nerve palsies.
- Tumor necrosis achieved in 60.7%, with complete contrast enhancement disappearance in 10.7%.
Conclusions:
- Preoperative embolization of tentorial tumors is feasible and effective.
- The procedure offers substantial benefits for subsequent surgical resection when performed with expertise.
- Acceptable risks are associated with this technique in complex skull base surgeries.
Related Concept Videos
Pulmonary Embolism I: Introduction
702
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
702
Pulmonary Embolism III: Nursing Management
439
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
439
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
448
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
448
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K

